CSOFT’s President and CEO, Shunee Yee, Interviewed by Doug Tsuruoka from Investor’s Business Daily

2010年8月25日

From Investor’s Business Daily Article:

When a U.S. company sells software to a big market like China, the product usually isn’t ready for use right out of the box.

Everything from the characters you see on the PC screen to the online help to the printed manuals need to be translated from English into Chinese, says Shunee Yee, the head of Beijing-based CSOFT International. Also, screen layouts and labels must be altered to cope with the switch to Chinese characters.

For this task, many companies turn to providers of localization services. These firms linguistically and culturally adapt products for sale in other markets.

Yee, who founded CSOFT in 2003 with a group of language technology specialists, has parlayed demand for localization services to turn her company into the 30th top-grossing language service provider in the world, according to Common Sense Advisory. The research firm says CSOFT is the No. 4 localization vendor in Asia. The region accounts for 7%, or $1.8 billion, of the global localization market.

Privately held CSOFT — observers estimate sales this year of $25 million to $28 million — has 13 offices in various markets, including Europe, North America and Australia.

Click here to read the full article.

About CSOFT Health Sciences

CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com

Media Contacts

Nikki Andrews (U.S./Europe)

Phone: +1 (617) 263-8950
Sidebar:
有任何问题?

欢迎随时与我们联系。